Sharekhan

Akums Drugs and Pharmaceuticals Ltd

Fri 11/07/2025,15:57:15 | NSE : AKUMS

₹ 557.957.05 (1.28%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 556.55

Previous Close

₹ 550.90

Volume

1180097

Mkt Cap ( Rs. Cr)

₹8781.80

High

₹ 592.00

Low

₹ 550.00

52 Week High

₹ 1175.90

52 Week Low

₹ 405.00

Book Value Per Share

₹ 180.08

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Akums Drugs and Pharmaceuticals Ltd

Your Vote -

Buy

69.57%

Hold

17.39%

Sell

13.04%

69.57%

23 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

557.95

103

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

103

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Akums Drugs and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Akums Drugs & Pharma - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    5 Jul 2025, 4:50PM AKUMS DRUGS AND PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Sh
  • Akums Drugs & Pharma - Resignation Of Senior Management Personnel

    5 Jul 2025, 4:47PM Resignation of Senior Management Personal
  • Akums Drugs & Pharma - Updates

    5 Jul 2025, 4:44PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Resignation of Senior Management Personnel'.
  • Akums Drugs & Pharma - Trading Window-XBRL

    26 Jun 2025, 4:09PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window
  • Akums Drugs & Pharma - Trading Window

    26 Jun 2025, 4:05PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradin
  • Akums Drugs & Pharma - Disclosure under SEBI Takeover Regulations

    25 Jun 2025, 7:38PM Akums Drugs and Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board
  • Akums Drugs & Pharma - Notice Of Shareholders Meetings-XBRL

    25 Jun 2025, 4:37PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 18-Jul
  • Akums Drugs & Pharma - Copy of Newspaper Publication

    25 Jun 2025, 3:07PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Akums Drugs & Pharma - Updates

    24 Jun 2025, 5:48PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Business stability and Sustainability Report '.
  • Akums Drugs & Pharma - Shareholders meeting

    24 Jun 2025, 4:19PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 18, 2025
  • Akums Drugs & Pharma - Business Responsibility and Sustainability Reporting (BRSR)

    24 Jun 2025, 5:18PM Business Responsibility and Sustainability Report for the Financial Year Ended 31.03.2025
  • Akums Drugs & Pharma - Reg. 34 (1) Annual Report.

    24 Jun 2025, 4:30PM Notice convening 21st Annual General Meeting and Integrated Annual Report of Financial Year 2024-25.
  • Akums Drugs & Pharma - Notice Convening 21St Annual General Meeting And Integrated Annual Report Of Financial Year 2024-25

    24 Jun 2025, 4:20PM Notice convening 21st Annual General Meeting and Intergrated Annual Report of Financial Year 2024-25
  • Akums Drugs & Pharma - Copy of Newspaper Publication

    18 Jun 2025, 12:09PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Akums Drugs & Pharma - Updates

    16 Jun 2025, 2:27PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'The company is hosting Plant Visit for Investors '.
  • Akums Drugs & Pharma - The Company Is Hosting Plant Visit For Investors

    16 Jun 2025, 2:27PM The company is hosting Plant Visit for Investors
  • Akums Drugs & Pharma - Updates

    7 Jun 2025, 4:49PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Approval of Revised Notice of Annual General Meeting ( AGM
  • Akums Drugs & Pharma - Intimation Of Appointment Of Additional Director (Non-Executive- Independent)

    4 Jun 2025, 7:17PM Intimation of Appointment of Additional Director (Non Executive- Independent)
  • Akums Drugs & Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Jun 2025, 5:37PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Transcript
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    2 Jun 2025, 5:40PM Earnings Call Transcript
  • Akums Drugs & Pharma - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    27 May 2025, 4:35PM AKUMS DRUGS AND PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Sh
  • Akums Drugs & Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    27 May 2025, 4:20PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Link of Recording
  • Akums Drugs & Pharma - Copy of Newspaper Publication

    27 May 2025, 1:09PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
  • Akums Drugs & Pharma - Updates

    27 May 2025, 11:19AM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Revised Analyst Investor Meet'.
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    27 May 2025, 4:27PM Audio Recording
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 May 2025, 11:22AM Revised Intimation of Analyst Investor Meet
  • Akums Drugs & Pharma - Updates

    26 May 2025, 8:00PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Analyst Meet'.
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 May 2025, 7:51PM Analyst Investor Meet
  • Akums Drugs & Pharma - Press Release

    26 May 2025, 7:43PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 26, 2025, titled ""Press Release"".
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    26 May 2025, 7:41PM Press Release
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    26 May 2025, 7:36PM Investor Presentation
  • Akums Drugs & Pharma - Investor Presentation

    26 May 2025, 7:35PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Investor Presentation
  • Akums Drugs & Pharma - Appointment Of SPG & Associates As A Secretarial Auditor, Appointment Of Balwinder & Associates As Cos

    26 May 2025, 7:25PM Appointment of SPG & Associates as a Secretarial Auditor, Appointment of Balwinder & Associates as Cost Auditor, and Resignation of Mr. Amrut Medhekar
  • Akums Drugs & Pharma - General Updates

    26 May 2025, 7:20PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about General Updates_Resignation of Mr. Amrut Medhekar, CEO-CDMO w.e.f 15.07.2025
  • Akums Drugs & Pharma posts Q4 net profit of Rs 27.59 cr

    26 May 2025, 7:13PM The company reported standalone net profit during the quarter stood at Rs 27.59 crore compared to net loss of Rs 57.87 crore in the previous year quar
  • Akums Drugs & Pharma - Board Meeting Outcome for Outcome Of Board Meeting

    26 May 2025, 7:02PM Outcome of Board Meeting
  • Akums Drugs & Pharma - Outcome of Board Meeting

    26 May 2025, 6:59PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on May 26, 2025.
  • Akums Drugs & Pharma - Outcome Of Board Meeting

    26 May 2025, 6:58PM Outcome of Board Meeting
  • Akums Drugs & Pharma - Outcome of Board Meeting

    26 May 2025, 6:52PM Akums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Akums Drugs & Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2025, 5:10PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 May 2025, 5:02PM Schedule of Analyst / Investor Meet
  • Akums Drugs & Pharma - Board Meeting Intimation

    19 May 2025, 4:24PM Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 26-May-2025 to inter-alia consider and approve the
  • Akums Drugs & Pharma - Board Meeting Intimation for Consideration And Approval Of Un-Audited (Standalone & Consolidated) Fina

    19 May 2025, 4:22PM Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia,
  • Akums Drugs & Pharma - Monitoring Agency Report

    14 May 2025, 12:15PM Monitoring Agency Report
  • Akums Drugs & Pharma - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    14 May 2025, 12:14PM Monitoring Agency Report

Key fundamentals

Evaluate the intrinsic value of Akums Drugs and Pharmaceuticals Ltd stock 

Name March-25 March-24
Assets 2309.177 370.164
Liabilities 2309.177 370.164
Equity 30.621 28.613
Gross Profit 138.499 -126.658
Net Profit 160.998 -165.451
Cash From Operating Activities 91.002 247.907
NPM(%) 12.27 -11.45
Revenue 1311.784 1444.119
Expenses 1173.285 1570.777
ROE(%) 5.68 -5.83

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Akums Drugs and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 905.60 0.25 30.05 318.75 301.39 0.55
Lotus Eye Hospital and Institute Ltd 73.05 -1.14 208.71 1161.47 3.55 0.00
Vaishali Pharma Ltd 12.76 -0.23 212.67 598.67 3.13 0.00
Astec Lifesciences Ltd 893.55 -0.53 0.00 1095.30 -601.21 0.00

Company Info

Our Company was incorporated as a public limited company under the Companies Act, 1956 as `Akums Drugs and Pharmaceuticals Limited', pursuant to a certificate of incorporation dated April 19, 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13, 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19, 20, 21, sector 6A, Haridwar, Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22, Sector 6A, Sidcul, Haridwar, Uttarakhand and sterile products at 2,3,4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48, Sector 6A, SIDCUL, Haridwar, Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47, Sector 6A, SIDCUL, Haridwar, Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai, Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar, Uttarakhand by Akums Healthcare Limited2022-Plant at 19, 20, 21, Sector 6A, SIDCUL, Haridwar, Uttarakhand and plant at 2, 3, 4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand accredited European Union-Good Manufacturing Practices, qualifying for exports to European markets-Acquisition of a facility in Haridwar, Uttarakhand by Akums Healthcare Limited and a facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Our Company was incorporated as a public limited company under the Companies Act, 1956 as `Akums Drugs and Pharmaceuticals Limited', pursuant to a certificate of incorporation dated April 19, 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13, 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19, 20, 21, sector 6A, Haridwar, Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22, Sector 6A, Sidcul, Haridwar, Uttarakhand and sterile products at 2,3,4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48, Sector 6A, SIDCUL, Haridwar, Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47, Sector 6A, SIDCUL, Haridwar, Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai, Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar, Uttarakhand by Akums Healthcare Limited2022-Plant at 19, 20, 21, Sector 6A, SIDCUL, Haridwar, Uttarakhand and plant at 2, 3, 4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand accredited European Union-Good Manufacturing Practices, qualifying for exports to European markets-Acquisition of a facility in Haridwar, Uttarakhand by Akums Healthcare Limited and a facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Read More

Parent Organisation

Akums Drugs & Pharmaceuticals Ltd.

Founded

19/04/2004

Managing Director

Mr.Sanjeev Jain

NSE Symbol

AKUMSEQ

FAQ

The current price of Akums Drugs and Pharmaceuticals Ltd is ₹ 557.95.

The 52-week high for Akums Drugs and Pharmaceuticals Ltd is ₹ 592.00 and the 52-week low is ₹ 550.00.

The market capitalization of Akums Drugs and Pharmaceuticals Ltd is currently ₹ 8781.80. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Akums Drugs and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Akums Drugs and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Akums Drugs and Pharmaceuticals Ltd shares.

The CEO of Akums Drugs and Pharmaceuticals Ltd is Mr.Sanjeev Jain, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT